Zacks Research Analysts Lower Earnings Estimates for Danaher

Danaher Co. (NYSE:DHR) – Research analysts at Zacks Research cut their Q1 2025 EPS estimates for shares of Danaher in a note issued to investors on Tuesday, March 25th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings per share of $1.61 for the quarter, down from their prior forecast of $1.62. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q2 2025 earnings at $1.76 EPS, Q3 2025 earnings at $1.85 EPS, FY2025 earnings at $7.59 EPS, Q1 2026 earnings at $1.84 EPS and FY2026 earnings at $8.50 EPS.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business earned $2.09 earnings per share.

Other analysts have also recently issued reports about the stock. JPMorgan Chase & Co. reduced their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research note on Friday, March 14th. The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, March 21st. Robert W. Baird reduced their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Barclays lowered their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.24.

Danaher Stock Down 0.1 %

Shares of Danaher stock opened at $210.26 on Thursday. The stock has a 50-day simple moving average of $215.23 and a 200-day simple moving average of $237.37. Danaher has a 52-week low of $196.80 and a 52-week high of $281.70. The firm has a market cap of $150.27 billion, a price-to-earnings ratio of 39.82, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Hedge Funds Weigh In On Danaher

A number of hedge funds have recently made changes to their positions in the business. Howard Capital Management Group LLC boosted its holdings in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares in the last quarter. Great Valley Advisor Group Inc. lifted its position in shares of Danaher by 3.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 1,646 shares of the conglomerate’s stock worth $458,000 after buying an additional 61 shares during the period. Harvest Fund Management Co. Ltd boosted its stake in Danaher by 544.6% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 954 shares of the conglomerate’s stock valued at $265,000 after buying an additional 806 shares in the last quarter. Truvestments Capital LLC bought a new stake in Danaher in the third quarter valued at $110,000. Finally, Qsemble Capital Management LP bought a new position in shares of Danaher during the third quarter valued at $555,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s payout ratio is currently 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.